FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216996955> ?p ?o ?g. }

• W3216996955 endingPage "388" @default.
• W3216996955 startingPage "379" @default.
• W3216996955 abstract "Volumetric muscle loss (VML) was defined as the frank loss of skeletal muscle tissue with associated chronic functional deficits. Significant effort has been dedicated to developing approaches for treating VML injuries, most of which have focused on stimulating regeneration of the affected musculature via a variety of approaches (e.g., biomaterials). VML injury induces a prolonged inflammatory response which causes fibrotic tissue deposition and is thought to inhibit de novo myofiber regeneration despite observed improvements in functional outcomes (i.e., functional fibrosis; FF). Recent approaches have sought to attenuate inflammation and/or fibrosis as a means to create a permissive environment for regenerative therapies. However, there are currently no clinically available interventions capable of facilitating full restoration of form and function following VML injury; thus, an unmet clinical need exists for a near-term interventional strategy to treat affected patients. FF could serve as an alternative approach to facilitate improved functional outcomes following VML injuries. We sought to investigate whether intentionally exploiting the concept of FF (i.e., induction of a supraphysiological fibrotic response via the delivery of a polypropylene mesh combined with TGFβ) would enhance the function of the VML affected musculature. We found that FF treatment induces enhanced fibrotic tissue deposition within the VML defect as evidenced by histological and molecular analysis. FF-treated animals exhibit improved in vivo muscle function compared to untreated control animals at 8 weeks post-injury, thus substantiating the concept that FF could serve as an efficacious approach for facilitating improved functional outcomes following VML injury. STATEMENT OF SIGNIFICANCE: VML injuries result in long-term functional impairments and reduced quality of life for affected individuals, namely combat injured US Service members, and no clinical interventions can restore the form and function of the injured limb. Extensive efforts have been aimed at developing therapeutics to address this critical gap; unfortunately, most interventions facilitate only modest regeneration. Interestingly, improved muscle function has been observed in VML studies following treatment with a therapeutic, despite a lack of myogenic tissue formation; a phenomenon termed Functional Fibrosis (FF). Herein we exploited the concept of FF to enhance the function of VML affected musculature. This finding is significant in that the commercially available interventions used to induce FF can be translated into the clinic near-term, thus improving the standard of care for VML injuries." @default.
• W3216996955 created "2021-12-06" @default.
• W3216996955 creator A5010179838 @default.
• W3216996955 creator A5015292833 @default.
• W3216996955 creator A5017158408 @default.
• W3216996955 creator A5022282078 @default.
• W3216996955 creator A5030510460 @default.
• W3216996955 creator A5062016727 @default.
• W3216996955 creator A5065702782 @default.
• W3216996955 date "2022-03-01" @default.
• W3216996955 modified "2023-10-16" @default.
• W3216996955 title "Evaluating the potential use of functional fibrosis to facilitate improved outcomes following volumetric muscle loss injury" @default.
• W3216996955 cites W1539252903 @default.
• W3216996955 cites W1756269602 @default.
• W3216996955 cites W1856771337 @default.
• W3216996955 cites W1974517758 @default.
• W3216996955 cites W2015692862 @default.
• W3216996955 cites W2030527446 @default.
• W3216996955 cites W2033507886 @default.
• W3216996955 cites W2069016577 @default.
• W3216996955 cites W2084113440 @default.
• W3216996955 cites W2152889855 @default.
• W3216996955 cites W2154250871 @default.
• W3216996955 cites W2167279371 @default.
• W3216996955 cites W2336642884 @default.
• W3216996955 cites W2585860091 @default.
• W3216996955 cites W2748956455 @default.
• W3216996955 cites W2768526122 @default.
• W3216996955 cites W2782584141 @default.
• W3216996955 cites W2794423958 @default.
• W3216996955 cites W2805296735 @default.
• W3216996955 cites W2806375716 @default.
• W3216996955 cites W2978074313 @default.
• W3216996955 cites W2995653818 @default.
• W3216996955 cites W3091476980 @default.
• W3216996955 cites W3118859245 @default.
• W3216996955 cites W3123572481 @default.
• W3216996955 cites W3152408782 @default.
• W3216996955 doi "https://doi.org/10.1016/j.actbio.2021.11.032" @default.
• W3216996955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34843950" @default.
• W3216996955 hasPublicationYear "2022" @default.
• W3216996955 type Work @default.
• W3216996955 sameAs 3216996955 @default.
• W3216996955 citedByCount "3" @default.
• W3216996955 countsByYear W32169969552022 @default.
• W3216996955 countsByYear W32169969552023 @default.
• W3216996955 crossrefType "journal-article" @default.
• W3216996955 hasAuthorship W3216996955A5010179838 @default.
• W3216996955 hasAuthorship W3216996955A5015292833 @default.
• W3216996955 hasAuthorship W3216996955A5017158408 @default.
• W3216996955 hasAuthorship W3216996955A5022282078 @default.
• W3216996955 hasAuthorship W3216996955A5030510460 @default.
• W3216996955 hasAuthorship W3216996955A5062016727 @default.
• W3216996955 hasAuthorship W3216996955A5065702782 @default.
• W3216996955 hasConcept C126322002 @default.
• W3216996955 hasConcept C142724271 @default.
• W3216996955 hasConcept C150903083 @default.
• W3216996955 hasConcept C171056886 @default.
• W3216996955 hasConcept C207001950 @default.
• W3216996955 hasConcept C207200792 @default.
• W3216996955 hasConcept C2776914184 @default.
• W3216996955 hasConcept C2778514504 @default.
• W3216996955 hasConcept C2779959927 @default.
• W3216996955 hasConcept C2780559512 @default.
• W3216996955 hasConcept C71924100 @default.
• W3216996955 hasConcept C86803240 @default.
• W3216996955 hasConcept C95444343 @default.
• W3216996955 hasConceptScore W3216996955C126322002 @default.
• W3216996955 hasConceptScore W3216996955C142724271 @default.
• W3216996955 hasConceptScore W3216996955C150903083 @default.
• W3216996955 hasConceptScore W3216996955C171056886 @default.
• W3216996955 hasConceptScore W3216996955C207001950 @default.
• W3216996955 hasConceptScore W3216996955C207200792 @default.
• W3216996955 hasConceptScore W3216996955C2776914184 @default.
• W3216996955 hasConceptScore W3216996955C2778514504 @default.
• W3216996955 hasConceptScore W3216996955C2779959927 @default.
• W3216996955 hasConceptScore W3216996955C2780559512 @default.
• W3216996955 hasConceptScore W3216996955C71924100 @default.
• W3216996955 hasConceptScore W3216996955C86803240 @default.
• W3216996955 hasConceptScore W3216996955C95444343 @default.
• W3216996955 hasFunder F4320306078 @default.
• W3216996955 hasFunder F4320338321 @default.
• W3216996955 hasFunder F4320338415 @default.
• W3216996955 hasLocation W32169969551 @default.
• W3216996955 hasLocation W32169969552 @default.
• W3216996955 hasOpenAccess W3216996955 @default.
• W3216996955 hasPrimaryLocation W32169969551 @default.
• W3216996955 hasRelatedWork W1981919236 @default.
• W3216996955 hasRelatedWork W2034457588 @default.
• W3216996955 hasRelatedWork W2058795891 @default.
• W3216996955 hasRelatedWork W2461129609 @default.
• W3216996955 hasRelatedWork W2521179722 @default.
• W3216996955 hasRelatedWork W2992759053 @default.
• W3216996955 hasRelatedWork W2995062801 @default.
• W3216996955 hasRelatedWork W3001086633 @default.
• W3216996955 hasRelatedWork W4353086860 @default.
• W3216996955 hasRelatedWork W572025462 @default.
• W3216996955 hasVolume "140" @default.

• next